Chronic Bronchitis Support Protocol
Primary Stack
Core supplements with strongest evidenceMucolytic that thins mucus; antioxidant; reduces exacerbation frequency and severity in COPD/chronic bronchitis
Supports immune function; deficiency very common in COPD; supplementation may reduce exacerbations especially if deficient
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsAnti-inflammatory; may reduce airway inflammation and improve lung function
Supporting Studies (1)
Bronchodilator effects; low levels associated with worse lung function; supports muscle function including respiratory muscles
Supporting Studies (1)
Antioxidant; may protect airways from oxidative damage; supports immune function
Supporting Studies (1)
Antioxidant that protects lung tissue from oxidative stress
Supporting Studies (1)
Supports immune function; may reduce duration of respiratory infections
Supporting Studies (1)
Flavonoid with anti-inflammatory and antioxidant properties; may support lung health
Supporting Studies (1)
May support immune function and reduce respiratory infection frequency
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Chronic bronchitis is characterized by inflammation and excess mucus production in the bronchial tubes, causing a persistent productive cough. It's defined as a cough with mucus production on most days for at least 3 months in 2 consecutive years. Chronic bronchitis is a form of COPD (Chronic Obstructive Pulmonary Disease) and is primarily caused by smoking.
CRITICAL: The most important intervention for chronic bronchitis is SMOKING CESSATION. This protocol is SUPPORTIVE and does not replace medical treatment or the need to quit smoking.
MEDICAL TREATMENT includes:
WHEN TO SEEK IMMEDIATE CARE:
* N-Acetyl Cysteine (NAC) is the most studied supplement for chronic bronchitis. It thins mucus (mucolytic effect) and has antioxidant properties. Multiple studies show it reduces the frequency and severity of exacerbations.
* Vitamin D deficiency is very common in COPD patients (up to 70%). Supplementation, especially in those with low levels, can reduce exacerbation frequency.
* Omega-3 Fatty Acids have anti-inflammatory properties that may reduce airway inflammation.
* Magnesium has mild bronchodilator effects and supports respiratory muscle function.
Expected timeline: NAC may reduce exacerbations within 3-6 months of regular use. Vitamin D benefits develop over weeks to months. Lung damage from smoking is partially irreversible, but stopping smoking halts further decline.
Clinical Perspective
Chronic Bronchitis: Clinical diagnosis - productive cough on most days for >=3 months in >=2 consecutive years, without other explanation. Part of COPD spectrum (with emphysema). Pathophysiology: airway inflammation, mucus gland hypertrophy, goblet cell metaplasia, impaired mucociliary clearance. Primary cause: smoking (85-90%); also air pollution, occupational exposures, alpha-1 antitrypsin deficiency. Complications: frequent exacerbations, respiratory failure, cor pulmonale.
CRITICAL: Smoking cessation is THE most important intervention - only proven way to slow disease progression. Medical management: GOLD guidelines for COPD - bronchodilators (LABA, LAMA), ICS if indicated, pulmonary rehab, vaccination, oxygen if hypoxic. Supplements are ADJUNCTIVE to guideline-directed medical therapy.
* N-Acetyl Cysteine (A-grade): Mucolytic; antioxidant; reduces exacerbations. Meta-analysis: (PMID: 26547527). Cochrane: (PMID: 28933948). 600-1200mg daily. Best evidence of any supplement for chronic bronchitis.
* Vitamin D (A-grade): Immune function; exacerbation reduction especially if deficient. Meta-analysis: RCTs (PMID: 30675873). 2000-4000 IU daily; higher if deficient (common in COPD).
* Omega-3 Fatty Acids (B-grade): Anti-inflammatory. Systematic review: (PMID: 27840029). 2-3g EPA+DHA daily.
* Magnesium (B-grade): Bronchodilation; respiratory muscles. Systematic review: (PMID: 28150472). 300-400mg daily.
* Vitamin C (C-grade): Antioxidant. Review: (PMID: 23075608). 500-1000mg daily.
* Vitamin E (C-grade): Antioxidant. Review: (PMID: 27918887). 200-400 IU daily.
* Zinc (C-grade): Immune function. Review: (PMID: 24580542). 15-30mg daily.
* Quercetin (C-grade): Anti-inflammatory. Review: (PMID: 26268530). 500-1000mg daily.
* Probiotics (C-grade): Immune modulation. Systematic review: (PMID: 27231050). 10-20 billion CFU daily.
Assessment targets: FEV1/FVC (spirometry), exacerbation frequency, CAT or mMRC scores, 6MWT, oxygen saturation, smoking status, vitamin D levels.
Protocol notes: Smoking cessation: most critical; NRT, varenicline, bupropion, counseling - offer at every visit. Pulmonary rehabilitation: exercise training + education; improves symptoms, exercise capacity, quality of life. Vaccinations: annual influenza, pneumococcal (PPSV23 + PCV13), COVID-19, Tdap - reduce infection risk. Exacerbation prevention: NAC, vitamin D, vaccination, adherence to maintenance inhalers. Mucus clearance: NAC helps; also adequate hydration, postural drainage, huffing technique. Oxygen: if PaO2 <55 or <60 with evidence of cor pulmonale; improves survival. Bronchodilators: cornerstone of treatment; LAMAs and LABAs alone or combined; ICS added if exacerbations continue. Roflumilast: PDE4 inhibitor for severe COPD with chronic bronchitis phenotype and frequent exacerbations. Air quality: avoid pollution, indoor smoke; air purifiers may help. Nutrition: COPD patients often malnourished; adequate calories and protein important.